bexarotene has been researched along with Leukemia, Myeloid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreadis, C; Bagg, A; Carroll, M; DiPatri, D; Ghalie, R; Goldsteini, S; Goradia, A; Kemner, A; Loren, AW; Luger, SM; Nowell, P; Perl, A; Porter, D; Schuster, S; Stadtmauer, EA; Swider, C; Thompson, JE; Tomczak, E; Tsai, DE | 1 |
| Abbassi, N; Deeg, HJ; Gopal, AK; Hockenbery, DM; Kiem, HP; Li, X; Pagel, JM; Seal, S; Ying, SX | 1 |
2 other study(ies) available for bexarotene and Leukemia, Myeloid
| Article | Year |
|---|---|
Evidence of myeloid differentiation in non-M3 acute myeloid leukemia treated with the retinoid X receptor agonist bexarotene.
Topics: Acute Disease; Aged; Antineoplastic Agents; Bexarotene; Bone Marrow; Cell Differentiation; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Myeloid Cells; Retinoid X Receptors; Tetrahydronaphthalenes | 2007 |
Differential effects of bexarotene on intrinsic and extrinsic pathways in TRAIL-induced apoptosis in two myeloid leukemia cell lines.
Topics: Anticarcinogenic Agents; Apoptosis; Benzoates; Bexarotene; Biphenyl Compounds; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 8; Caspase 9; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Gene Expression Regulation, Leukemic; Humans; Lentivirus; Leukemia, Myeloid; Tetrahydronaphthalenes; TNF-Related Apoptosis-Inducing Ligand | 2007 |